Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism.
Nomura M, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Inagaki N, Yamamoto K, Otsuki M, Yabe D, Izawa S, Takahashi Y, Suzuki T, Yasoda A, Tanabe A, Naruse M; JPAS/JRAS Study Group.
Nomura M, et al.
Hypertens Res. 2022 Sep;45(9):1476-1485. doi: 10.1038/s41440-022-00960-x. Epub 2022 Jun 28.
Hypertens Res. 2022.
PMID: 35764671